Jun 10, 2026
15 MIN READ

Is Mounjaro a Semaglutide? Understanding the Differences and Similarities

Mounjaro and semaglutide are often confused, but they're different medications that work through distinct biological pathways. Understanding their similarities and differences helps you make informed decisions about your weight loss treatment.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 10, 2026
15 MIN READ

is mounjaro a semaglutide? understanding the differences and similarities — PlexusDx GLP-1 education

Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many people ask whether Mounjaro is a form of semaglutide, but the answer is no—they are two separate medications that work through different mechanisms in your body. Both belong to the GLP-1 receptor agonist class, but Mounjaro (tirzepatide) activates an additional pathway that semaglutide does not, making them uniquely suited for different individuals based on their genetic and metabolic profiles.

Semaglutide and Tirzepatide Are Different Medications

Semaglutide and tirzepatide (Mounjaro) are not interchangeable drugs, even though both were designed to help with weight loss and metabolic health. Semaglutide activates only the GLP-1 receptor, a single hormone pathway in your brain and gut that signals fullness and reduces appetite. Tirzepatide, by contrast, activates both GLP-1 and GIP receptors simultaneously, creating a dual-pathway effect that some patients find more effective.

The structural differences between these compounds mean they have different pharmacokinetics—how your body absorbs, distributes, and eliminates them. Semaglutide reaches peak blood levels within 1–3 days of injection, while tirzepatide works through a longer-acting mechanism that maintains steadier levels throughout the week. These timing differences can influence how quickly you feel results and how your body adapts to the medication over time.

How GLP-1 and GIP Pathways Affect Weight Loss Results

GLP-1 receptors are found throughout your brain's appetite centers, your pancreas, and your gastrointestinal tract, making semaglutide effective at reducing hunger and slowing stomach emptying. This single-pathway approach has strong clinical evidence: semaglutide achieved average weight loss of 15% in the STEP trials over 68 weeks. However, not every person responds equally to GLP-1 alone, which is where genetic variation plays a role.

Tirzepatide's dual mechanism—activating both GLP-1 and GIP—taps into an additional weight regulation pathway that can produce stronger metabolic effects in some individuals. In clinical trials, tirzepatide users lost up to 22% of their body weight, suggesting the GIP component enhances results for certain patients. Your genetic makeup, specifically variants in the GLP1R and GIPR genes, influences how strongly each medication will work for you, which is why personalized testing matters.

Similarities Between Semaglutide and Tirzepatide

Both medications reduce appetite by mimicking glucagon-like peptide-1, a natural hormone your body produces after eating. They slow gastric emptying (how fast food moves through your stomach), increase feelings of fullness, and help regulate blood sugar levels. Both are administered as once-weekly injections or daily oral formulations, offering flexibility based on your preference and lifestyle.

Common side effects are similar between the two: nausea, vomiting, constipation, and diarrhea occur more frequently during the first few weeks as your body adjusts. Both are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. And both require dose escalation over several weeks to reach maintenance levels, though your total monthly cost remains flat regardless of your dose progression.

Why Genetic Testing Helps You Choose the Right Medication

Your response to semaglutide versus tirzepatide is partly determined by genetic variants in peptide-pathway genes, not standard pharmacogenomic markers. PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and identifies variations in GLP1R, GIPR, FTO, and MC4R genes that predict how effectively each medication will work for your body. For example, individuals with certain GLP1R variants may experience superior appetite suppression from semaglutide alone, while others benefit more from tirzepatide's dual activation.

The Precision Peptide Genetic Test provides 150+ genetic insights that map to your specific peptide metabolism, helping PlexusDx clinicians personalize your treatment plan from the start. Rather than guessing which medication suits you best, you get data-driven guidance based on your unique biology. This test is available as a $99 add-on after your first month of treatment, allowing you to optimize your protocol based on genetic predisposition rather than trial and error.

Access Semaglutide and Tirzepatide Through PlexusDx

PlexusDx compounds both semaglutide and tirzepatide through licensed 503A compounding pharmacies, making them accessible in all 50 states without insurance requirements or membership fees. Compounded Semaglutide Injection starts at $149 per month, while Compounded Tirzepatide Injection begins at $249 per month—and your dose may increase, but your price will not. Both medications are HSA/FSA eligible, helping reduce out-of-pocket costs for eligible patients.

If you prefer oral formulations, PlexusDx offers Oral Semaglutide at $249 per month and Oral Tirzepatide at $279 per month, each with the same flat-pricing guarantee. For patients interested in exploring both pathways simultaneously, the GLP-Squared Injection (combining semaglutide and tirzepatide in one compound) starts at $249 per month. Your PlexusDx clinician will recommend the best starting point based on your medical history, goals, and genetic profile once you add the Precision Peptide Genetic Test.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Mounjaro the same as semaglutide?

No. Mounjaro is the brand name for tirzepatide, which activates GLP-1 and GIP receptors. Semaglutide activates only GLP-1 receptors. They are distinct medications with different mechanisms, though both help reduce appetite and support weight loss through different biological pathways.

Which medication produces better weight loss results?

Clinical trials show tirzepatide achieved up to 22% weight loss, while semaglutide achieved approximately 15% in comparable studies. However, individual results vary based on genetics, metabolism, and adherence. Your genetic profile (including GLP1R and GIPR variants) influences which medication will work most effectively for your body.

Can I switch from semaglutide to tirzepatide or vice versa?

Yes, many patients switch between medications under clinical guidance if one isn't producing desired results after adequate time and dose titration. PlexusDx clinicians can help you transition safely and monitor your response. Genetic testing through the Precision Peptide Genetic Test can inform whether a switch is likely to improve your outcomes.

What does PlexusDx charge for semaglutide and tirzepatide?

Compounded Semaglutide Injection starts at $149 per month, and Compounded Tirzepatide Injection starts at $249 per month. Your dose may increase over time, but your monthly price remains flat. Both are available through licensed 503A compounding pharmacies nationwide and are HSA/FSA eligible.

How does the Precision Peptide Genetic Test help me choose between these medications?

The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to predict your individual response to each medication. This $99 add-on identifies which drug class or dual-pathway option will likely work best for your unique genetic makeup, helping PlexusDx clinicians personalize your treatment from the start rather than relying on trial and error.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves